News Vinay Prasad abruptly departs from the FDA The disruption at the FDA continues with the departure of CBER director Vinay Prasad, less than three months after taking on the role.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
